Noura Elsedawy, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Patent
    Ineligible company:
    Vyriad
    Topic:
    Oncolytic virotherapy
    Date added:
    05/02/2025
    Date updated:
    05/02/2025
    Relationship end date:
    06/15/2023
Return to Case-Based Insights on Hematologic Malignancies